Live Crown Castle Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

TG THERAPEUTICS, INC.

TGTX

Latest SEC Filings from TG THERAPEUTICS, INC.

  1. 1
    1

    TG Therapeutics Reports 70.3% Revenue Growth to $240.3 Million in Latest Quarter

    via official filing (AI summary) 3 months ago 0 comments
  2. 2
    1

    TG Therapeutics Reports 69.7% Revenue Growth to $204.9 Million in Latest Quarter

    via official filing (AI summary) 6 months ago 0 comments
  3. 3
    1

    TG Therapeutics Reports $616.3 Million Revenue for Fiscal Year 2025, Driven by BRIUMVI Sales

    via official filing (AI summary) 8 months ago 0 comments
  4. 4
    1

    TG Therapeutics Reports $161.7 Million Revenue in Latest Quarter, Driven by BRIUMVI Sales

    via official filing (AI summary) 12 months ago 0 comments
  5. 5
    1

    TG Therapeutics Reports $141.1 Million Revenue in Q2 2025, Driven by BRIUMVI Sales

    via official filing (AI summary) about 1 year ago 0 comments
  6. 6
    1

    TG Therapeutics Reports $120.9 Million Revenue and $5.1 Million Net Income in Latest Quarter

    via official filing (AI summary) over 1 year ago 0 comments
  7. 7
    1

    TG Therapeutics Reports $23.38 Million Net Income for Fiscal Year 2024, Driven by BRIUMVI Revenue Growth

    via official filing (AI summary) over 1 year ago 0 comments
  8. 8
    1

    TG Therapeutics Reports Significant Revenue Growth, Net Income Decline in Q3 2024

    via official filing (AI summary) almost 2 years ago 0 comments